| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 5e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |